Adma Biologics (ADMA) closed the last trading session at $18.01, gaining 5.8% over the past four weeks, but there could be ...

Axogen (NASDAQ:AXGN) and ADMA Biologics (NASDAQ:ADMA) said on Monday that they expect minimal to no impact from the tariffs ...

ADMA is a U.S.-based company with all manufacturing operations, end-market sales, and customer engagements conducted exclusively within the United States,” said Adam Grossman, President and Chief ...

ADMA Biologics (ADMA) provided a statement on the recent tariffs put in place and reiterated ADMA’s strategic advantage through fully ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

In this article, we are going to take a look at where ADMA Biologics Inc. (NASDAQ:ADMA) stands against other Wednesday’s top performers. The stock market regained momentum on Wednesday ...

In the latest trading session, Adma Biologics (ADMA) closed at $18.67, marking a +1.3% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.64%. Elsewhere, the Dow saw an ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

At ADMA, David Morgan has been announced as the chair of its Advisory Committee. Meanwhile, Steve Brennan is the vice ...